Xsensio

Lausanne, Switzerland

Xsensio develops Lab-on-Skin technology for next-generation wearables that enable real-time biochemical sensing for healthcare applications.

$7.0M raised

Mar 2026

Series A

Top Investors

European Innovation CouncilVenture KickWI Harper GroupPrivilège VenturesPropel(X)

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Xsensio raised?

Xsensio has raised $7.0M in total funding. The most recent round was Series A. The last funding was announced in March 2026.

Who are Xsensio's investors?

Xsensio's investors include European Innovation Council, Venture Kick, WI Harper Group, Privilège Ventures, Propel(X).

Where is Xsensio headquartered?

Xsensio is headquartered in Lausanne, Switzerland.

What does Xsensio do?

Xsensio develops Lab-on-Skin technology for next-generation wearables that enable real-time biochemical sensing for healthcare applications.

What stage is Xsensio at?

Xsensio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 2, 2026.

MLA

"Xsensio — Funding & Investors." VCBacked, March 2, 2026, https://www.vcbacked.co/company/xsensio. Accessed June 3, 2026.

APA

VCBacked. (2026). Xsensio — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/xsensio

Wikipedia (cite web)

{{cite web |title=Xsensio — Funding & Investors |url=https://www.vcbacked.co/company/xsensio |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 2, 2026.